Novel Type 1 diabetes treatment involves transplantation of insulin-producing pancreas cells

In a new study, a team of researchers from the University of Missouri, Georgia Tech and Harvard University has demonstrated the successful use of a novel Type 1 diabetes treatment in a large animal model.

Related Keywords

Chengdu ,Sichuan ,China ,Georgia ,United States ,Harvard University ,Massachusetts ,Missouri ,University Of Missouri ,Georgia Institute Of Technology ,Missourians ,American ,Rudy Matheson ,Michael Hunckler ,Ivy Rosales ,Kevin Deng ,Kang Lee ,Emily Henderson ,Zhao Luo ,Alexander Zhang ,Zhongliang Zou ,Zhongping Deng ,Zhenjuan Wang ,Nikolaos Serifis ,Lisa Kojima ,Cole Peters ,Zhihong Yang ,Haval Shirwan ,Andres Garc ,Jim Markmann ,Georgia Institute Of Technology Tech ,National Institutes Of Health ,Roy Blunt Nextgen Precision Health ,National Science Foundation Graduate Research Fellowship ,Diabetes Research Foundation ,Mu School Of Medicine ,Nextgen Precision Health ,American Association For The Advancement Of Science ,Colleen Mccoy At Massachusetts Institute Of Technology ,Georgia Tech Research Corporation ,University Of Louisville ,Georgia Tech ,Esma Yolcu ,Science Advances ,American Association ,Juvenile Diabetes Research Foundation ,National Institutes ,National Science Foundation Graduate Research ,James Markmann ,Georgia Institute ,General Hospital ,Western Theater Command ,Tao Chen ,Xiamen University Medical School ,Colleen Mccoy ,Massachusetts Institute ,Jessica Weaver ,Haley Tector ,Diabetes ,Immune System ,Type 1 Diabetes ,Animal Model ,Poptosis ,Flood ,Blood Sugar ,Fell ,Child Health ,Drugs ,Efficacy ,Ormone ,Mmunology ,Insulin ,Juvenile Diabetes ,Medicine ,Icrobiology ,Olecule ,Pancreas ,Research ,